Page last updated: 2024-08-26

terameprocol and B16 Melanoma

terameprocol has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amin, S; Anderson, KC; Avet-Loiseau, H; Fulciniti, M; Hideshima, T; Li, C; Minvielle, S; Munshi, NC; Nanjappa, P; Prabhala, R; Rodig, S; Tai, YT; Tassone, P1
Dorr, RT; Lambert, JD; Meyers, RO; Timmermann, BN1

Other Studies

2 other study(ies) available for terameprocol and B16 Melanoma

ArticleYear
Significant biological role of sp1 transactivation in multiple myeloma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Oct-15, Volume: 17, Issue:20

    Topics: Animals; Apoptosis; Bone Marrow Cells; Cell Cycle; Cell Proliferation; Cell Survival; Gene Knockdown Techniques; Humans; Male; Masoprocol; Melanoma, Experimental; Mice; Mice, SCID; Multiple Myeloma; RNA Interference; Sp1 Transcription Factor; Transcriptional Activation; Tumor Cells, Cultured

2011
tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo.
    Cancer letters, 2001, Sep-28, Volume: 171, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle; Colonic Neoplasms; DNA Replication; Female; Intracellular Membranes; Kidney; Liver; Lung Neoplasms; Male; Masoprocol; Melanoma; Melanoma, Experimental; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, SCID; Mitochondria; Neoplasm Transplantation; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001